ERAS
Erasca, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.62
+1.72%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-79.4%
Return on equity
-66.0%
Return on assets
-37.6%
Return on invested capital
0.00x
Asset turnover
-$98.0M
Cash from operations
$0.77
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026